Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Weight Loss 1Lung Neoplasms 1Fatigue 1Depression 1Carcinoma, Non-Small-Cell Lung 1Cachexia 1Anxiety Disorders 1Advanced Cancer 1Adenocarcinoma of Lung 1

Interventions

Therapeutics 20Exercise 16Yoga 15Modafinil 12Surveys and Questionnaires 11Psychiatric Rehabilitation 10Methylphenidate 7Acupuncture Therapy 7Therapeutic Touch 6Ultraviolet Therapy 5Educational Status 5Acceptance and Commitment Therapy 5Walking 4Sugars 4Physical Therapy Modalities 4Palliative Care 4Early Intervention, Educational 4Control Groups 4Behavior Therapy 4methyl hydroxyethyl cellulose 3Touch 3Exercise Therapy 3Epoetin Alfa 3Counseling 3Acupressure 3Standard of Care 2Sodium Chloride 2Resistance Training 2Qigong 2Music Therapy 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Fatigue × Fluoxetine × Clear all
NCT00005850 2016-07-04

Combination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer

Alliance for Clinical Trials in Oncology

Phase 2 Completed
21 enrolled
Thoracic

Adenocarcinoma of Lung, Anxiety Disorders, Carcinoma, Non-Small-Cell Lung, Depression, Fatigue, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡